3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
9
Lymphoma, Non-Hodgkin
7
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Melanoma
2
Lymphoma
2
Cytokine Release Syndrome
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Craniopharyngioma
1
Interventions
Oxaliplatin
29
Fluorouracil
23
Capecitabine
19
pembrolizumab
18
Nivolumab
17
Leucovorin
16
Docetaxel
10
Trastuzumab
9
Paclitaxel
9
Drug Therapy
9
Cisplatin
9
fludarabine
8
S 1 (combination)
8
Cyclophosphamide
8
Specimen Handling
7
trastuzumab deruxtecan
6
Bevacizumab
6
Magnetic Resonance Spectroscopy
5
Biopsy
5
zolbetuximab
4
Irinotecan
4
Carboplatin
4
zimberelimab
3
sintilimab
3
olaparib
3
fludarabine phosphate
3
durvalumab
3
atezolizumab
3
aldesleukin
3
XELOX
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
tocilizumab
×
90 days
×
Clear all
No trials found.